國際精密(00929.HK)斥6,666萬人幣建常熟廠房
國際精密(00929.HK)公布,間接全資附屬公司江蘇科達與承包商簽訂建造合約,據此,承包商同意進行位於江蘇省常熟經濟技術開發區東周路6號總樓面面積約28,977平方米之6號廠房及其他配套設施之建造工程,合約總價為6,666萬元人民幣。
承包商須負責該廠房的建造工程,包括但不限於土建工程;椿基工程;主要結構建造工程;水電安裝工程;及缺陷責任期內可能發現該廠房的質量缺陷之所有修正工程。建造工程預期將於建造工程施工後285日內完成。根據建造合約,預期施工日為今年8月28日,預期竣工日為明年6月13日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.